Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
-
* Corresponding author: Daniel J Clauw dclauw@med.umich.edu
Arthritis Research & Therapy 2008, 10:211 doi:10.1186/ar2443
Accesses
- Last 30 days: 101 accesses
- Last year: 1461 accesses
- All time: 10275 accesses
Cited by
BioMed Central: 4 citations
|
Research article
Claudia Lerma, Aline Martinez, Natllely Ruiz, Angelica Vargas, Oscar Infante, Manuel Martinez-Lavin Arthritis Research & Therapy 2011, 13:R185 (16 November 2011) Nocturnal heart rate variability parameters indicative of sympathetic predominance are significantly different in fibromyalgia patients compared to healthy individuals, and correlate with several symptoms including pain severity.
|
|
Research article
Toward characterization and definition of fibromyalgia severity Stuart Silverman, Alesia Sadosky, Chris Evans, Yating Yeh, Jose Ma J Alvir, Gergana Zlateva BMC Musculoskeletal Disorders 2010, 11:66 (8 April 2010) Patients who self-rate their fibromyalgia (FM) as severe report greater pain and sleep interruption and use more fibromyalgia medication, suggesting that these comorbid variables may be used to define FM severity.
|
|
Review
Developments in the scientific and clinical understanding of fibromyalgia Dan Buskila Arthritis Research & Therapy 2009, 11:242 (14 October 2009) This article is part of a collection on The Scientific Basis of... |
